Published in CNS Drugs on January 01, 2004
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci (2005) 0.97
Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care. Neuropsychiatr Dis Treat (2013) 0.93
Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. J Neurol Neurosurg Psychiatry (2006) 0.82
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial. BMC Psychiatry (2011) 0.79
The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population. BMC Psychiatry (2015) 0.79
Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial. Int Arch Med (2013) 0.78
A review of quetiapine in combination with antidepressant therapy in patients with depression. Neuropsychiatr Dis Treat (2007) 0.77
Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions. AAPS PharmSciTech (2013) 0.77
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study. Neuropsychiatr Dis Treat (2013) 0.75
Evaluation of bioequivalence of two oral formulations of olanzapine. Indian J Pharm Sci (2011) 0.75
[Pharmacotherapy for schizophrenia]. Nervenarzt (2006) 0.75
Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain. Metab Brain Dis (2017) 0.75
Gabapentin: in postherpetic neuralgia. CNS Drugs (2003) 2.03
Azelaic acid 15% gel: in the treatment of papulopustular rosacea. Am J Clin Dermatol (2004) 2.03
Ultra-short-course seasonal allergy vaccine (Pollinex Quattro). Drugs (2006) 1.47
Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs (2009) 1.27
Tranexamic acid: a review of its use in the management of menorrhagia. Drugs (2003) 1.13
Spotlight on zanamivir in influenza. Am J Respir Med (2002) 1.11
Cetuximab: in the treatment of metastatic colorectal cancer. Drugs (2004) 1.08
Lamotrigine: a review of its use in bipolar disorder. Drugs (2003) 0.97
Nebivolol: a review of its use in the management of hypertension and chronic heart failure. Drugs (2006) 0.96
Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs (2003) 0.92
Octreotide long-acting release (LAR): a review of its use in the management of acromegaly. Drugs (2003) 0.91
Ranibizumab. Drugs (2007) 0.87
Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. Drugs (2003) 0.87
Panitumumab: in the treatment of metastatic colorectal cancer. Drugs (2006) 0.86
The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions. Am J Cardiovasc Drugs (2004) 0.85
Lapatinib. Drugs (2007) 0.85
Zanamivir: an update of its use in influenza. Drugs (2002) 0.84
Low-dose doxepin: in the treatment of insomnia. CNS Drugs (2010) 0.83
Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus. Drugs (2004) 0.83
Sorafenib: in advanced renal cancer. Drugs (2007) 0.82
Intravenous droperidol: a review of its use in the management of postoperative nausea and vomiting. Drugs (2006) 0.82
Lacidipine: a review of its use in the management of hypertension. Drugs (2003) 0.82
Spotlight on lamotrigine in bipolar disorder. CNS Drugs (2004) 0.82
Alemtuzumab. Drugs (2003) 0.81
Spotlight on fondaparinux sodium in acute coronary syndromes. BioDrugs (2008) 0.81
Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy. Drugs (2005) 0.81
Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive. Treat Endocrinol (2003) 0.81
Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Drugs (2004) 0.80
Inhaled iloprost: in primary pulmonary hypertension. Drugs (2004) 0.80
Emtricitabine/tenofovir disoproxil fumarate. Drugs (2004) 0.80
Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women. Treat Endocrinol (2002) 0.80
Etanercept: a review of its use in the management of plaque psoriasis and psoriatic arthritis. Am J Clin Dermatol (2005) 0.79
Intranasal sumatriptan: in adolescents with migraine. CNS Drugs (2005) 0.79
Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women. Drugs (2005) 0.79
Tamsulosin: an update of its role in the management of lower urinary tract symptoms. Drugs (2002) 0.78
Fondaparinux sodium: a review of its use in the management of acute coronary syndromes. Am J Cardiovasc Drugs (2008) 0.78
Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension. Drugs (2005) 0.78
Solifenacin in overactive bladder syndrome. Drugs Aging (2005) 0.77
Valdecoxib. Drugs (2002) 0.77
Rivastigmine in Parkinson's disease dementia: profile report. Drugs Aging (2007) 0.76
Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer. Drugs (2006) 0.75
Panitumumab in the treatment of metastatic colorectal cancer: profile report. BioDrugs (2007) 0.75
Mammalian cell-derived somatropin : a review of its use in the management of HIV-associated wasting. Drugs (2006) 0.75
Subcutaneous interferon-beta-1a : new formulation. CNS Drugs (2007) 0.75
Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer. Drugs (2004) 0.75
Enoxaparin: a review of its use as thromboprophylaxis in acutely ill, nonsurgical patients. Drugs (2005) 0.75
Spotlight on mammalian cell-derived somatropin in HIV-associated wasting. BioDrugs (2006) 0.75
Spotlight on etanercept in plaque psoriasis and psoriatic arthritis. BioDrugs (2005) 0.75
Sucrose-formulated octocog alfa: a review of its use in patients with haemophilia A. Drugs (2008) 0.75
Ciclesonide nasal spray: in allergic rhinitis. Drugs (2008) 0.75
Spotlight on fluvoxamine in anxiety disorders in children and adolescents. CNS Drugs (2002) 0.75
Ethinylestradiol/chlormadinone acetate. Drugs (2004) 0.75
Rivastigmine: in Parkinson's disease dementia. CNS Drugs (2006) 0.75